How do you better target receptors for therapeutic antibody-based medicines?

Pleased to announce my latest review on describing the difficulties of targeting, and overcoming, one of the worlds most attractive and targets in cancer - the HER2 receptor. I hope that this review draws inspiration on how to study and improve targeting for researchers working on their own antibody/receptor systems. Enjoy!